Minnesota medical device maker Cardiovascular Systems (NSDQ:CSII) announced that it raised $84.5 million through sales of 3 million shares of its common stock.
Wall Street Beat
Vital Therapies delays IPO on ‘poor market conditions’
San Diego, Calif.-based Vital Therapies Inc. decided to put off its initial public offering for an undisclosed period of time, hoping market conditions will improve for its liver failure cell-based therapy.
The IPO was supposed to launch this week, according to Renaissance Capital IPO Center, which cited "poor market conditions" as the reason for the delay.
Cyberonics soars on a strong Q2 results, record sales, boosted guidance
Cyberonics (NSDQ:CYBX) saw some significant interest from Wall Street today after posting record sales for its 2nd quarter and increasing its projections for the rest of the year.
Listen to Cyberonics’ Q2 2014 earnings call
Hologic braces against a potential takeover
Unilife shares surge on $40M Hikma supply deal
Tandem Diabetes closes $138M IPO
Tandem Diabetes Care (NSDQ:TNDM) closed its initial public offering yesterday after selling all 9.2 million shares on offer for $15 apiece, raising $138 million.
Cardiovascular Systems’ public offering could garner $70M
Cardiovascular Systems (NSDQ:CSII) announced this week an upcoming stock offering worth up to $70 million in net proceeds, according to an early estimate.
Bovie Medical records more red in Q3
Bovie Medical (NYSE:BVX) reported its earnings for the 3rd quarter, where it took a hit in both lower sales and widening losses.
Bovie Medical posted losses of $341,000, or -2¢ per share, on sales of $5.8 million for the 3 months ended Sept. 30. Losses jumped nearly 5000% on a sales decrease of 13.2% compared with the same period last year.